Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 54%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic ste...

Industry: Biotechnology
Sector: Healthcare
Phone: 86 571 8538 9730
Fax: 86 571 8538 9730
Address:
12/F, Building D, 198 Qidi Road, HIPARK Xiaoshan District, Hangzhou, China
Latest News on ASCLF
No data available.